Dose-response evaluation of cyclic estrogen/gestagen in postmenopausal women: Placebo-controlled trial of its gynecologic and metabolic actions

American Journal of Obstetrics and Gynecology

Volumn 144, Issue 8, 1982, Pages 873-879

  Christensen, Merete Sanvig ^a,b   Hagen, Claus ^a,b   Christiansen, Claus ^a,b   Transbøl, Ib ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; ESTRADIOL; ESTRIOL; ESTROGEN; GESTAGEN; NORETHISTERONE ACETATE; PLACEBO; TRIACYLGLYCEROL; TRISEQUENS;

BLOOD PRESSURE; BONE MASS; CARDIOVASCULAR SYSTEM; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG RESPONSE; DRUG THERAPY; ENDOCRINE SYSTEM; FEMALE GENITAL SYSTEM; FOLLITROPIN BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; THERAPY; VOLUNTEER;

ADULT; BLOOD PRESSURE; BONE AND BONES; CALCIUM; CHOLESTEROL; CLIMACTERIC; CLINICAL TRIALS; COMPARATIVE STUDY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ESTROGENS; FEMALE; HUMAN; MENOPAUSE; MENSTRUATION; MIDDLE AGE; NORETHINDRONE; PROGESTATIONAL HORMONES, SYNTHETIC; RANDOM ALLOCATION; SUPPORT, NON-U.S. GOV'T;

EID: 0020461042     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9378(82)90176-4     Document Type: Article

References (20)

1. Menopause and coronary heart disease. The Framingham study
2. Postmenopausal and corticosteroid-induced osteoporosis
3. Effects of long-term estrogen replacement therapy. I. Metabolic effects
4. Menopausal oestrogen therapy and protection from ischaemic heart disease
5. Estrogens and postmenopausal osteoporosis
6. Prevention of early postmenopausal bone loss: Controlled 2-year study in 315 normal females
7. Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy
8. Postmenopausal oestrogens protect against fractures of hip and distal radius. A case-control study
9. Effect of natural oestrogen replacement therapy on menopausal symptoms and blood clotting
10. Estrogen-replacement therapy—Help or hazard
11. Effects of long-term estrogen replacement therapy. II. Neoplasia
12. Reduced incidence of endometrial cancer among postmenopausal women treated with progestogens
13. Long-term reproducibility of bone mineral content measurements
14. Contemporary therapy of the menopausal syndrome
15. Effects of natural oestrogen/gestagen and thiazide on coronary risk factors in normal postmenopausal women. A 2-year double-blind placebo study
16. Treatment of postmenopausal hypercholesterolaemia with estradiol
17. The Tromsö heart study: High density lipoprotein and coronary heart disease. A prospective case-control study
18. Risk of vascular disease in women. Smoking, oral contraceptives, non-contraceptive estrogens, and other factors
19. Effects of different progestogens on lipoproteins during postmenopausal replacement therapy
20. Estrogen use in postmenopausal women—costs, risks and benefits